248 related articles for article (PubMed ID: 32780766)
1. Observational study of ocular surface squamous neoplasia: Risk factors, diagnosis, management and outcomes at a tertiary eye hospital in South Africa.
Hӧllhumer R; Williams S; Michelow P
PLoS One; 2020; 15(8):e0237453. PubMed ID: 32780766
[TBL] [Abstract][Full Text] [Related]
2. Ocular surface squamous neoplasia: management and outcomes.
Hӧllhumer R; Williams S; Michelow P
Eye (Lond); 2021 Jun; 35(6):1562-1573. PubMed ID: 33564137
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
Venkateswaran N; Mercado C; Galor A; Karp CL
Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
[TBL] [Abstract][Full Text] [Related]
4. Topical 1% 5-fluorouracil eye drops as primary treatment for ocular surface squamous neoplasia: Long-term follow-up study.
Wylegala A; Sripawadkul W; Zein M; Alvarez OP; Al Bayyat G; Galor A; Karp CL
Ocul Surf; 2023 Jan; 27():67-74. PubMed ID: 36476665
[TBL] [Abstract][Full Text] [Related]
5. Long term study of topical interferon α-2b eye drops as primary treatment of ocular surface squamous neoplasia.
Sripawadkul W; Reyes-Capo D; Zein M; Wylegala A; Albayyat G; Galor A; Karp CL
Ocul Surf; 2023 Apr; 28():108-114. PubMed ID: 36592780
[TBL] [Abstract][Full Text] [Related]
6. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
Kaliki S; Bejjanki KM; Desai A; Mohamed A
Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
[TBL] [Abstract][Full Text] [Related]
7. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment.
Leventer I; Singh H; Pashaee B; Raimondo CD; Khakh CK; Martin JL; Acharya B; Zhang Q; Lally SE; Shields CL
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100052. PubMed ID: 38521390
[TBL] [Abstract][Full Text] [Related]
8. Management of Ocular Surface Squamous Neoplasia with Topical and Intralesional Interferon Alpha 2B in Mexicans.
Nava-Castañeda Á; Hernández-Orgaz J; Garnica-Hayashi L; Ansart A; Matus G; Tovilla-Canales JL
Nepal J Ophthalmol; 2018 Jul; 10(20):143-150. PubMed ID: 31056557
[TBL] [Abstract][Full Text] [Related]
9. Comparison of non-invasive diagnostic modalities for ocular surface squamous neoplasia at a tertiary hospital, South Africa.
Hӧllhumer R; Michelow P; Williams S
Eye (Lond); 2024 Apr; 38(6):1118-1124. PubMed ID: 37996734
[TBL] [Abstract][Full Text] [Related]
10. Ocular surface squamous neoplasia: angiographic characteristics and response to subconjunctival/perilesional 5-fluorouracil injections.
Sun Y; Hua R
Drug Des Devel Ther; 2019; 13():1323-1334. PubMed ID: 31118569
[No Abstract] [Full Text] [Related]
11. Optical coherence tomography angiography in the evaluation of vascular patterns of ocular surface squamous neoplasia during topical medical treatment.
Theotoka D; Liu Z; Wall S; Galor A; Al Bayyat GJ; Feuer W; Jianhua W; Karp CL
Ocul Surf; 2022 Jul; 25():8-18. PubMed ID: 35358712
[TBL] [Abstract][Full Text] [Related]
12. Medical treatment for ocular surface squamous neoplasia.
Monroy D; Serrano A; Galor A; Karp CL
Eye (Lond); 2023 Apr; 37(5):885-893. PubMed ID: 36754986
[TBL] [Abstract][Full Text] [Related]
13. Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia.
Kieval JZ; Karp CL; Abou Shousha M; Galor A; Hoffman RA; Dubovy SR; Wang J
Ophthalmology; 2012 Mar; 119(3):481-6. PubMed ID: 22154538
[TBL] [Abstract][Full Text] [Related]
14. Extending far and wide: the role of biopsy and staging in the management of ocular surface squamous neoplasia.
Polski A; Sibug Saber M; Kim JW; Berry JL
Clin Exp Ophthalmol; 2019 Mar; 47(2):193-200. PubMed ID: 30156057
[TBL] [Abstract][Full Text] [Related]
15. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
Chaugule SS; Park J; Finger PT
Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety and cost-effectiveness of 5-fluorouracil versus interferon α-2b as adjuvant therapy after surgery in ocular surface squamous neoplasia in a southern European tertiary hospital.
San Román Llorens JJ; Fernández-Gurria M; Artaechevarria Artieda J; Alejandre Alba N; García Sandoval B; Jiménez-Alfaro Morote I
Int Ophthalmol; 2024 Apr; 44(1):184. PubMed ID: 38630143
[TBL] [Abstract][Full Text] [Related]
17. Effect of Pegylated Interferon and Mitomycin C on Ocular Surface Squamous Neoplasia in Xeroderma Pigmentosum: A Case Series.
Dirar QS; Musalem HM; Al-Hazzaa SAF; Al Zoba AA; Almalki AA
Am J Case Rep; 2020 Apr; 21():e921301. PubMed ID: 32251268
[TBL] [Abstract][Full Text] [Related]
18. Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia.
Thomas BJ; Galor A; Nanji AA; El Sayyad F; Wang J; Dubovy SR; Joag MG; Karp CL
Ocul Surf; 2014 Jan; 12(1):46-58. PubMed ID: 24439046
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Medical Management of Ocular Surface Squamous Neoplasia.
Sayed-Ahmed IO; Palioura S; Galor A; Karp CL
Expert Rev Ophthalmol; 2017; 12(1):11-19. PubMed ID: 28184236
[TBL] [Abstract][Full Text] [Related]
20. Challenging Treatment of Ocular Surface Squamous Neoplasia in Patients with Atopic Disease.
Zhang L; Mercado C; Galor A; Holland EJ; Wang G; Karp CL
Ocul Immunol Inflamm; 2019; 27(2):288-293. PubMed ID: 29190165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
